Michael C. Zlupko

Michael Zlupko practices at Encompass Health Rehabilitation Hospital of Altoona in Altoona, Pennsylvania, part of Encompass Health.

Michael Zlupko's NPI, 1114121647, was assigned on June 11, 2007. Michael Zlupko graduated from Perelman School of Med at the University of Pennsylvania in 2007. Michael Zlupko holds Pennsylvania license MD447263.

Michael Zlupko's primary practice is Encompass Health Rehabilitation Hospital of Altoona, at 2005 Valley View Boulevard, Altoona, PA 16602 in Blair County. The practice phone is (814) 944-3535.

Michael Zlupko's primary practice is Encompass Health Rehabilitation Hospital of Altoona in Altoona, Pennsylvania, part of Encompass Health. Michael Zlupko is also affiliated with UPMC Altoona. The medical group on file is UPMC Primary Care, Williamsburg Family Practice. Dmand AI also links Michael Zlupko to 4 more hospitals, 3 group practices and clinics, 3 medical groups and 2 hospices, each named with a free account. Michael Zlupko's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Zlupko practices, 11 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Michael Zlupko's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Michael Zlupko is licensed in Pennsylvania.

CMS data shows 2,724 Medicare services from Michael Zlupko across 16 procedure codes in 2024, for 522 Medicare patients. Medicare paid $174,118 for them.

CMS counts 522 Medicare patients who saw Michael Zlupko in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Zlupko's median patient age at 71, with 56% women.

In 2024, Michael Zlupko wrote 3,251 Medicare Part D claims for 439 patients. CMS names the drug for 3,117 of them, across 36 drugs with 11 or more claims each, at $1,997,079 in total drug cost. In 2023, CMS named 3,053 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Michael Zlupko for performance year 2024, reported as part of a group. Michael Zlupko accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Zlupko as offering telehealth.

CMS Open Payments shows 1,779 general payments to Michael Zlupko from 58 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. GlaxoSmithKline, LLC. paid the most, $217,920.

Michael Zlupko graduated from Perelman School of Med at the University of Pennsylvania in 2007.